COVID Vaccines For 5 to 11-Year-Old Children: Roll-Out in CT Expected to Begin in November
On October 27, the Food and Drug Administration’s independent advisory group recommended that the Pfizer-BioNTech application for Emergency Use Authorization (EUA) for its COVID-19 vaccine for children aged 5 through 11 be approved.
Read More